Disease #05520 (migraine (migraine (MGR)))

Official abbreviation migraine
Name migraine (MGR)
OMIM ID -
Inheritance -
Individuals reported having this disease 426
Phenotype entries for this disease 417
Associated with 0 genes -
Associated tissues -
Disease features -
Remarks -


Individuals

426 entries on 5 pages. Showing entries 1 - 100.
Legend   How to query   « First ‹ Prev     1 2 3 4 5     Next › Last »

AscendingIndividual ID     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Disease     

Phenotype details     

Genes screened

Variants in genes

Variants     

Panel size     

Owner     
00207087 - PubMed: Tonelli 2007 Triggering factors of hemiplegic migraine: physical and emotional stress F - Italy - - 0 - Triptans migraine 1st hemiplegic migraine attack 30y, duration 1st aura 3-5hmin, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 3-4h, 1st HMA moderate ATP1A2 ATP1A2 1 1 Paola Carrera
00207088 - PubMed: Tonelli 2007 Triggering factors of hemiplegic migraine: physical and emotional stress F - Italy - - 0 - Triptans migraine 1st hemiplegic migraine attack 40y, duration 1st aura 1-3dmin, 1st HMA hemiparesis left, 1st HMA hemiparesis not right, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 5-6h, 1st HMA severe ATP1A2 ATP1A2 1 1 Paola Carrera
00207089 - PubMed: Tonelli 2007 Triggering factors of hemiplegic migraine: physical and emotional stress M - Italy - - 0 - Triptans migraine 1st hemiplegic migraine attack 14y, duration 1st aura 1-3dmin, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 3-4h, 1st HMA severe ATP1A2 ATP1A2 1 1 Paola Carrera
00207090 - PubMed: Riant 2005 Genotyping of relatives identified 6 mutation carriers, among whom 5 were clinically affected. In addition 1 phenocopy was present. F - France - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207091 - PubMed: Vanmolkot 2007 - - - - - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 2 3 Paola Carrera
00207092 - PubMed: Spadaro 2004 - F - Italy - - 0 - no treatment known migraine 1st hemiplegic migraine attack 52y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA confusion/somnolence; PermCer status nystagmus, dysarthria, ataxia, MRI(72 years) marked cerebellar and vermis atrophy ATP1A2 ATP1A2 1 1 Paola Carrera
00207093 - PubMed: Spadaro 2004 - F - Italy - - 0 - Phenobarbital 100 mg/day migraine 1st hemiplegic migraine attack 25y, 1st HMA hemiparesis left, 1st HMA hemiparesis right, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA confusion/somnolence; 1st severe attack 25y, 1st severe attack signs Somnolence/fever/epileptic Seizures; PermCer status nystagmus, dysarthria, ataxia, MRI diffuse edema;cerebellar signs ATP1A2 ATP1A2 1 1 Paola Carrera
00207095 - PubMed: Spadaro 2004 - M - Italy - - 0 - no treatment known migraine 1st hemiplegic migraine attack 29y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA confusion/somnolence; 1st severe attack signs mild coma/fever ATP1A2 ATP1A2 1 1 Paola Carrera
00207096 - PubMed: Spadaro 2004 - M - Italy - - 0 - no treatment known migraine 1st hemiplegic migraine attack 21y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA confusion/somnolence; 1st severe attack signs mild coma/fever ATP1A2 ATP1A2 1 1 Paola Carrera
00207097 - PubMed: Spadaro 2004 - F - Italy - - 0 - no treatment known migraine 1st hemiplegic migraine attack 34y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207098 - PubMed: Spadaro 2004 - F - Italy - - 0 - no treatment known migraine 1st hemiplegic migraine attack 12y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack 12y, 1st severe attack hemiparesis not left, 1st severe attack hemiparesis right, 1st severe attack signs confusion/mild coma/fever/epileptic Seizures ATP1A2 ATP1A2 1 1 Paola Carrera
00207099 - PubMed: Spadaro 2004 - M - Italy - - 0 - no treatment known migraine 1st hemiplegic migraine attack 6y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack signs Somnolence/confusion/mild coma/fever ATP1A2 ATP1A2 1 1 Paola Carrera
00207100 - PubMed: Spadaro 2004 - F - Italy - - 0 - no treatment known migraine 1st hemiplegic migraine attack 26y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207101 - PubMed: Kaunisto 2004 - F - Finland - - 0 - no treatment known migraine 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA mild ATP1A2 ATP1A2 1 1 Paola Carrera
00207103 - PubMed: Castro 2007 - F - Portugal - - 0 - - migraine 1st hemiplegic migraine attack 13y, duration 1st aura 15min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207104 - PubMed: Castro 2007 - F - Portugal - - 0 - - migraine 1st hemiplegic migraine attack 5y, duration 1st aura 15min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe ATP1A2 ATP1A2 1 1 Paola Carrera
00207105 - PubMed: Castro 2007 - M - Portugal - - 0 - - migraine 1st hemiplegic migraine attack 7y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe ATP1A2 ATP1A2 1 1 Paola Carrera
00207106 - PubMed: Castro 2007 - F - Portugal - - 0 - - migraine 1st hemiplegic migraine attack 14y, duration 1st aura 600min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe ATP1A2 ATP1A2 1 1 Paola Carrera
00207107 - PubMed: Castro 2007 - M - Portugal - - 0 - - migraine 1st hemiplegic migraine attack 12y, duration 1st aura 15min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe ATP1A2 ATP1A2 1 1 Paola Carrera
00207108 - PubMed: Castro 2007 - M - Portugal - - 0 - - migraine 1st hemiplegic migraine attack 8y, duration 1st aura 60min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe ATP1A2 ATP1A2 1 1 Paola Carrera
00207109 - PubMed: Castro 2007 - F - Portugal - - 0 - - migraine unaffected ATP1A2 ATP1A2 1 1 Paola Carrera
00207110 - PubMed: Castro 2007 - M - Portugal - - 0 - - migraine 1st hemiplegic migraine attack 10y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe ATP1A2 ATP1A2 1 1 Paola Carrera
00207111 - PubMed: Castro 2007 - F - Portugal - - 0 - - migraine 1st hemiplegic migraine attack 14y, duration 1st aura 20min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe ATP1A2 ATP1A2 1 1 Paola Carrera
00207112 - PubMed: Castro 2007 - F - Portugal - - 0 - - migraine 1st hemiplegic migraine attack 6y, duration 1st aura 10min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe ATP1A2 ATP1A2 1 1 Paola Carrera
00207113 - PubMed: Riant 2005 Genotyping of relatives identified 2 mutation carriers, clinically affected. M - Italy - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207114 - PubMed: Riant 2005 Genotyping of relatives identified 5 mutation carriers, among whom 4 were clinically affected, and 1 with clinical information unavailable. M - France - - 0 - - migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207115 - PubMed: Swoboda 2004 - F - Greece - - 0 - Flunarizine migraine 1st HMA language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; PermCer status, no nystagmus, dysarthria, no ataxia ATP1A2 ATP1A2 1 1 Paola Carrera
00207116 - PubMed: Swoboda 2004 - M - Greece - - 0 - Flunarizine migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207117 - PubMed: Swoboda 2004 - M - Greece - - 0 - Flunarizine migraine 1st hemiplegic migraine attack 2y, 1st HMA language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207118 - PubMed: Swoboda 2004 - M - Greece - - 0 - Flunarizine migraine 1st hemiplegic migraine attack 1y, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207119 - PubMed: Jurkat-Rott 2004 - F - Germany - - 0 - no treatment known migraine 1st hemiplegic migraine attack 11y, duration 1st aura 300min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207120 - PubMed: Lebas 2008 - F - France - - 0 - paracetamol migraine 1st hemiplegic migraine attack 13y, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA confusion/somnolence, 1st HMA duration headache 2d ATP1A2 ATP1A2 1 1 Paola Carrera
00207121 - PubMed: Lebas 2008 - M - France - - 0 - - migraine 1st hemiplegic migraine attack 13y, duration 1st aura 15min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 48h; 1st severe attack 13y, duration aura 4, 1st severe attack signs confusion/fever ATP1A2 ATP1A2 1 1 Paola Carrera
00207122 - PubMed: Lebas 2008 - F - France - - 0 - paracetamol migraine 1st hemiplegic migraine attack 7y, duration 1st aura 60min, 1st HMA hemiparesis left, 1st HMA hemiparesis not right, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 4d ATP1A2 ATP1A2 1 1 Paola Carrera
00207123 - PubMed: Lebas 2008 - F - France - - 0 - sodium valproate migraine 1st hemiplegic migraine attack 4y, duration 1st aura 15min, 1st HMA hemiparesis left, 1st HMA hemiparesis not right, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack 5y, 1st severe attack signs confusion/fever/epileptic seizures ATP1A2 ATP1A2 1 1 Paola Carrera
00207124 - PubMed: Vanmolkot 2006 Haplotype analysis showed that the mutation occurred de novo. F - Netherlands - - 0 - valproic acid, improved migraine 1st hemiplegic migraine attack 4y, duration 1st aura 30min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207125 - PubMed: Vanmolkot 2006 - F - Netherlands - - 0 - - migraine 1st hemiplegic migraine attack 17y, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207126 - PubMed: Riant 2005 Genotyping of relatives identified 2 mutation carriers, clinically affected. M - France - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207127 - PubMed: Riant 2005 Genotyping of relatives identified 3 mutation carriers, clinically affected. M - Portugal - - 0 - - migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207129 - PubMed: Jen 2007 The young girl developed left-sided numbness and paralysis after 2 days of a severe right-sided headache.The hemiparesis was dense for 5 days and then gradually resolved over the next few days. F - - white - 0 - - migraine 1st hemiplegic migraine attack 9y, 1st HMA hemiparesis left, 1st HMA hemiparesis not right, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 2d, 1st HMA severe ATP1A2 ATP1A2 1 1 Paola Carrera
00207130 - PubMed: Riant 2005 Genotyping of relatives identified 1 mutation carrier, clinically affected. F - Switzerland - - 0 - - migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207131 - PubMed: Vanmolkot 2006 p.Gly615Arg is located in the highly conserved "TGD" motif of the ATP-binding domain. F - Netherlands - - 0 - - migraine episodes sometimes provoked by phisical exercise or a fall on the head; 1st hemiplegic migraine attack 3y, 1st HMA language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207132 - PubMed: Vanmolkot 2006 In the proband , this mutation is associated with a drastic clinical phenotype consisting of both episodic and permanent severe neurological features starting at a young age; The episodic symptoms were precipitated by mild head trauma and included hemiplegia,epileptic seizures and cortical blindness; Her father (II.6) reported that he, his brother (II.5) and his sister (II.4) were diagnosed with childhood epilepsy. Retrospectively, II.4, II.5 and II.6 most likely had hemiplegic migraine with a few episodes of confusional migraine; The p.Gly615Arg is located in the highly conserved "TGD" motif of the ATP-binding domain. F - Netherlands - - 0 - Acetazolamide, resolution symptoms migraine 1st hemiplegic migraine attack 4y, 1st HMA hemiparesis left, 1st HMA hemiparesis not right, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA visual disturbances, 1st HMA confusion/somnolence; 1st severe attack 4y, 1st severe attack signs Somnolence/confusion/fever/epileptic seizures ATP1A2 ATP1A2 1 1 Paola Carrera
00207133 - PubMed: Vanmolkot 2006 Family 1 is the first Turkish family reported with FHM; haplotype analysis showed that the mutation occurred "de novo". F - Turkey - - 0 - - migraine 1st hemiplegic migraine attack 13y, duration 1st aura 30min, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207134 - PubMed: Vanmolkot 2006 Twin brother IV.2. Two affected sisters (IV.3, IV.4) with the p. Val628Met mutation; Family 1 is the first Turkish family reported with FHM. M - Turkey - - 0 - - migraine 1st hemiplegic migraine attack 18y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207135 - PubMed: Vanmolkot 2006 Twin brother IV.1. Two affected sisters (IV.3, IV.4) with the p. Val628Met mutation; Family 1 is the first Turkish family reported with FHM. M - Turkey - - 0 - - migraine 1st hemiplegic migraine attack 13y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207136 - PubMed: Vanmolkot 2006 Family 1 is the first Turkish family reported with FHM F - Turkey - - 0 - - migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207137 - PubMed: Vanmolkot 2006 Family 1 is the first Turkish family reported with FHM. F - Turkey - - 0 - - migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207139 - PubMed: Vanmolkot 2003, PubMed: Terwindt 1997 - F - Netherlands - - 0 - no treatment known migraine 1st hemiplegic migraine attack 14y, duration 1st aura 105min, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207140 - PubMed: Vanmolkot 2003 - F - Netherlands - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207142 - PubMed: Vanmolkot 2003 - F - Netherlands - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207143 - PubMed: Vanmolkot 2003, PubMed: Terwindt 1997 - M - Netherlands - - 0 - no treatment known migraine 1st hemiplegic migraine attack 14y, duration 1st aura 60min, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207144 - PubMed: Vanmolkot 2003, PubMed: Terwindt 1997 - F - Netherlands - - 0 - no treatment known migraine 1st hemiplegic migraine attack 10y, duration 1st aura 60min, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207146 - PubMed: Vanmolkot 2003, PubMed: Terwindt 1997 - M - Netherlands - - 0 - no treatment known migraine 1st hemiplegic migraine attack 18y, duration 1st aura 120min, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207147 - PubMed: Vanmolkot 2003 - M - Netherlands - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207148 - PubMed: Vanmolkot 2003, PubMed: Terwindt 1997 - F - Netherlands - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207149 - PubMed: Vanmolkot 2003 - M - Netherlands - - 0 - no treatment known migraine 1st hemiplegic migraine attack 19y, duration 1st aura 120min, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207150 - PubMed: Vanmolkot 2003, PubMed: Terwindt 1997 - M - Netherlands - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207151 - PubMed: Vanmolkot 2003, PubMed: Terwindt 1997 - F - Netherlands - - 0 - no treatment known migraine 1st hemiplegic migraine attack 10y, duration 1st aura 75min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA confusion/somnolence, 1st HMA duration headache 720min ATP1A2 ATP1A2 1 1 Paola Carrera
00207152 - PubMed: Vanmolkot 2003 - F - Netherlands - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207153 - PubMed: Vanmolkot 2003, PubMed: Terwindt 1997 - M - Netherlands - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack 4y, 1st severe attack signs confusion ATP1A2 ATP1A2 1 1 Paola Carrera
00207155 - PubMed: Vanmolkot 2003, PubMed: Terwindt 1997 - M - Netherlands - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207157 - PubMed: Pierelli 2006 - F - Italy - - 0 - - migraine cold weather and stress were potent attack triggers; 1st hemiplegic migraine attack 6y, duration 1st aura 60min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 180min ATP1A2 ATP1A2 1 1 Paola Carrera
00207158 - PubMed: Pierelli 2006 The patient identified several triggers for his attacks, including physical or emotional stress, alcohol intake, cold, minor head trauma and "roasted coffee" smell. M - Italy - - 0 - - migraine 1st hemiplegic migraine attack 10y, duration 1st aura 30min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 1d, 1st HMA moderate; 1st severe attack signs confusion ATP1A2 ATP1A2 1 1 Paola Carrera
00207159 - PubMed: Pierelli 2006 His first migraine attack was after a minor head trauma sustained while playing soccer; With the exception of the visual disturbances,which disappeared rapidly, full neurological recovery took a few days; He experienced severe attacks with confusion and drowsiness. ; When aged 40, after a cerebral angiography, the procedure was followed by a coma state lasting 3 days. M - Italy - - 0 - - migraine 1st hemiplegic migraine attack 10y, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack signs Somnolence/confusion ATP1A2 ATP1A2 1 1 Paola Carrera
00207160 - PubMed: Jurkat-Rott 2004 - F - Germany - - 0 - no treatment known migraine 1st hemiplegic migraine attack 10y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA confusion/somnolence, 1st HMA duration headache 420min ATP1A2 ATP1A2 1 1 Paola Carrera
00207161 - PubMed: Jurkat-Rott 2004 - F - Germany - - 0 - no treatment known migraine 1st hemiplegic migraine attack 8y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence; PermCer status no nystagmus, no dysarthria, ataxia ATP1A2 ATP1A2 1 1 Paola Carrera
00207162 - PubMed: Jurkat-Rott 2004 - M - Germany - - 0 - no treatment known migraine 1st hemiplegic migraine attack 12y, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207163 - PubMed: Jurkat-Rott 2004 - F - Germany - - 0 - no treatment known migraine 1st hemiplegic migraine attack 4y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence; PermCer status nystagmus, no dysarthria, no ataxia, Bilateral cerebellar infarcts on MRI ATP1A2 ATP1A2 1 1 Paola Carrera
00207164 - PubMed: Jurkat-Rott 2004 - F - Germany - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207165 - PubMed: Jurkat-Rott 2004 - F - Germany - - 0 - no treatment known migraine 1st hemiplegic migraine attack 10y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack 10y, duration aura 14, 1st severe attack signs complex visual and auditory delusions; PermCer status no nystagmus, no dysarthria, ataxia ATP1A2 ATP1A2 1 1 Paola Carrera
00207166 - PubMed: Jurkat-Rott 2004 - F - Germany - - 0 - no treatment known migraine 1st HMA language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack 3y, duration aura 6, 1st severe attack signs confusion/fever; PermCer status no nystagmus, no dysarthria, ataxia ATP1A2 ATP1A2 1 1 Paola Carrera
00207167 - PubMed: Castro 2007 - F - Portugal - - 0 - - migraine 1st hemiplegic migraine attack 15y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA mild ATP1A2 ATP1A2 1 1 Paola Carrera
00207168 - PubMed: Castro 2007 - M - Portugal - - 0 - - migraine 1st hemiplegic migraine attack 10y, duration 1st aura 15min, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA moderate ATP1A2 ATP1A2 1 1 Paola Carrera
00207169 - PubMed: Castro 2007 - F - Portugal - - 0 - - migraine 1st hemiplegic migraine attack 11y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA severe ATP1A2 ATP1A2 1 1 Paola Carrera
00207170 - PubMed: Castro 2007 - F - Portugal - - 0 - - migraine 1st hemiplegic migraine attack 9y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA mild ATP1A2 ATP1A2 1 1 Paola Carrera
00207171 - PubMed: Vanmolkot 2003 - F - Netherlands - - 0 - no treatment known migraine 1st hemiplegic migraine attack 9y, 1st HMA language disturbances, 1st HMA no sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207172 - PubMed: Vanmolkot 2003 - M - Netherlands - - 0 - no treatment known migraine 1st hemiplegic migraine attack 11y, duration 1st aura 15min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207173 - PubMed: Vanmolkot 2003 - F - Netherlands - - 0 - no treatment known migraine 1st hemiplegic migraine attack 7y, 1st HMA hemiparesis left, 1st HMA hemiparesis right, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207174 - PubMed: Vanmolkot 2003 - F - Netherlands - - 0 - no treatment known migraine 1st hemiplegic migraine attack 14y, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207175 - PubMed: Vanmolkot 2003 - F - Netherlands - - 0 - no treatment known migraine 1st hemiplegic migraine attack 3y, duration 1st aura 30min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207176 - PubMed: Jurkat-Rott 2004 - M - Germany - - 0 - no treatment known migraine 1st hemiplegic migraine attack duration 1st aura 210min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack 13y, 1st severe attack signs confusion/complex visual and auditory delusions/fever; PermCer status, White matter lesions ATP1A2 ATP1A2 1 1 Paola Carrera
00207178 - PubMed: Jurkat-Rott 2004 - M - Germany - - 0 - no treatment known migraine 1st hemiplegic migraine attack 7y, duration 1st aura 42min, 1st HMA language disturbances, 1st HMA no sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207179 - PubMed: De Fusco 2003 - M - Italy - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207180 - PubMed: De Fusco 2003 - M - Italy - - 0 - Acetazolamide migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207182 - PubMed: De Fusco 2003 - M - Italy - - 0 - Acetazolamide migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207184 - PubMed: De Fusco 2003 - F - Italy - - 0 - Acetazolamide migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207185 - PubMed: Jurkat-Rott 2004 - F - Germany - - 0 - no treatment known migraine 1st hemiplegic migraine attack 41y, duration 1st aura 30min, 1st HMA language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 720min ATP1A2 ATP1A2 1 1 Paola Carrera
00207186 - PubMed: Riant 2005 Genotyping of relatives identified 6 mutation carriers, among whom 4 were clinically affected, and 1 with uncertain clinical diagnosis. F - France - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207187 - PubMed: Riant 2005 Genotyping of relatives identified 14 mutation carriers, among whom 10 were clinically affected and 2 with uncertain clinical diagnosis. In addition 2 phenocopies were present. M - France - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207188 - PubMed: De Fusco 2003 - F - Italy - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207190 - PubMed: De Fusco 2003 - M - Italy - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207191 - PubMed: Jurkat-Rott 2004 Another paper (PMID 15985592: Dreier JP et al.) describes delayed cerebral edema in a patient with the p.Glu902Lys substitution. M - Germany - - 0 - no treatment known migraine 1st HMA language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack 0y, duration aura 20, 1st severe attack signs confusion/Severe coma/fever ATP1A2 ATP1A2 1 1 Paola Carrera
00207192 - PubMed: Riant 2005 Genotyping of relatives identified 7 mutation carriers, among whom 4 were clinically affected. F - France - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207193 - PubMed: Riant 2005 Genotyping of relatives identified 1 mutation carrier, clinically affected. M - France - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207194 - PubMed: Riant 2005 Genotyping of relatives identified 1 mutation carrier, clinically affected. F - France - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207195 - PubMed: Jurkat-Rott 2004 - M - Germany - - 0 - no treatment known migraine 1st hemiplegic migraine attack 20y, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence ATP1A2 ATP1A2 1 1 Paola Carrera
00207196 - PubMed: Jurkat-Rott 2004 - F - Germany - - 0 - no treatment known migraine 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA visual disturbances, 1st HMA no confusion/somnolence; 1st severe attack 23y, duration aura 2, 1st severe attack signs confusion; PermCer status nystagmus, no dysarthria, ataxia ATP1A2 ATP1A2 1 1 Paola Carrera
00207197 - PubMed: Jurkat-Rott 2004 - F - Germany - - 0 - no treatment known migraine 1st hemiplegic migraine attack 4y, 1st HMA no language disturbances, 1st HMA no sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence; PermCer status no nystagmus, no dysarthria, ataxia ATP1A2 ATP1A2 1 1 Paola Carrera
00207198 - PubMed: Jurkat-Rott 2004 - M - Germany - - 0 - no treatment known migraine 1st hemiplegic migraine attack 6y, duration 1st aura 15min, 1st HMA no language disturbances, 1st HMA sensory disturbances, 1st HMA no visual disturbances, 1st HMA no confusion/somnolence, 1st HMA duration headache 180min ATP1A2 ATP1A2 1 1 Paola Carrera
Legend   How to query   « First ‹ Prev     1 2 3 4 5     Next › Last »